PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 6, 2025BMC Cancer2 citationsOpen Access

Prognostic Nutritional Index and Patient Survival with Hepatocellular Carcinoma on Immune Checkpoint

Prognostic nutritional index and the survival of patients with hepatocellular carcinoma on immune checkpoint inhibitors: a meta-analysis

View Full Paper

Authors

WPWei PengJJJinqiong JiangTDTan Deng

Discussion

Loading...

Member takes

Overview

Meta-analysis reveals prognostic marker predicting survival in hepatocellular carcinoma patients on immune checkpoint inhibitors.

Key Points

  • Low pretreatment prognostic nutritional index linked to poorer survival outcomes in hepatocellular carcinoma patients.
  • Analysis showed that low PNI is associated with reduced overall survival and progression-free survival rates.
  • Meta-analysis across multiple studies evaluated the role of PNI as a prognostic indicator for patients receiving immune checkpoint inhibitors.
  • Further studies are warranted to confirm the validity of PNI as an established biomarker in this population.
Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Peng et al. (2025) studied this question.

synapsesocial.com/papers/694020f72d562116f28fb3d2https://doi.org/10.1186/s12885-025-15310-6
Ask AI
Helpful
Bookmark
Share
View Full Paper